These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6123119)

  • 1. Pharmacological manipulation of milk-induced behaviors in three-day-old rat pups.
    Caza PA; Spear LP
    Pharmacol Biochem Behav; 1982 Mar; 16(3):481-6. PubMed ID: 6123119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogenetic transitions in the psychopharmacological response to serotonergic manipulations.
    Enters EK; Spear LP
    Psychopharmacology (Berl); 1988; 96(2):161-8. PubMed ID: 3148141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quipazine-induced behavior in neonatal rat pups.
    Spear LP; Ristine LA
    Pharmacol Biochem Behav; 1981 Jun; 14(6):831-4. PubMed ID: 7255519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serotonergic agonists and antagonists on the locomotor activity of neonatal rats.
    Lucot JB; Seiden LS
    Pharmacol Biochem Behav; 1986 Mar; 24(3):537-41. PubMed ID: 3486425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in preweanling rat pups.
    Frambes NA; Kirstein CL; Moody CA; Spear LP
    Eur J Pharmacol; 1990 Jun; 182(1):9-17. PubMed ID: 2144825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suckling behavior of the infant rat: modulation by a developing neurotransmitter system.
    Nock B; Williams CL; Hall WG
    Pharmacol Biochem Behav; 1978 Mar; 8(3):277-80. PubMed ID: 206914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on general behaviour and neurotransmitter functions of a new 5-hydroxytryptamine3 receptor antagonist with potential therapeutic relevance in central nervous system disturbances.
    Rizzi CA; Prudentino A; Giraldo E
    Arzneimittelforschung; 1993 Oct; 43(10):1033-41. PubMed ID: 7903536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT(1A) receptor subsensitivity in infancy and supersensitivity in adulthood in an animal model of depression.
    Shayit M; Yadid G; Overstreet DH; Weller A
    Brain Res; 2003 Aug; 980(1):100-8. PubMed ID: 12865163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists.
    Dringenberg HC; Zalan RM
    Brain Res; 1999 Aug; 837(1-2):242-53. PubMed ID: 10434009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacological effects of MK-801 in infant and preweanling rat pups.
    Rajachandran L; Goodwin GA; Spear LP
    Pharmacol Biochem Behav; 1991 Oct; 40(2):291-5. PubMed ID: 1805233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suckling behavior in neonatal rats: psychopharmacological investigations.
    Spear LP; Ristine LA
    J Comp Physiol Psychol; 1982 Apr; 96(2):244-55. PubMed ID: 6121827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of serotonin-mediated behavioral inhibition in the hyperthyroid mouse.
    Nagy ZM; Forster MJ
    Pharmacol Biochem Behav; 1982 Feb; 16(2):203-6. PubMed ID: 7071073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in neonatal rat pups.
    Kirstein CL; Spear LP
    Eur J Pharmacol; 1988 Jun; 150(3):339-45. PubMed ID: 2970973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early behavioral effects of lead perinatal exposure in rat pups.
    De Marco M; Halpern R; Barros HM
    Toxicology; 2005 Jul; 211(1-2):49-58. PubMed ID: 15863247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and behavioral responses in pre-weanling rats following alteration of maternal diet.
    Swithers SE; Melendez RI; Watkins BA; Davis RJ
    Physiol Behav; 2001 Jan; 72(1-2):147-57. PubMed ID: 11239992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.